Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Alicia Basir’s April Love Ritual Reconnects Sweethearts for 2026 Wedding

April 4, 2026

Vapofil Claims Evaluated: 2026 Report on Vapofil Ingredients, Pricing, and What Consumers Should Verify Before Purchasing

April 4, 2026

CFIA continues recall for Tim Hortons heat-activated mugs after reports of burn risk

April 4, 2026

HDFC ERGO Shares Tips on Keeping Your No-Claim Bonus Growing for Bigger Long-Term Savings

April 4, 2026

Free Spins No Deposit Casino Bonus 2026 | Online Casino Real Money No Deposit By My Bookie

April 4, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Press Release

TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit

By News RoomMay 23, 20252 Mins Read
TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) —

Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Treace Medical Concepts, Inc. (TMCI) Misled Investors Regarding Demand for its Primary Product

According to the complaint, during the class period, defendants failed to disclose that (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System, and (2) as a result, Treace Medical’s revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function). Plaintiff alleges that when the truth was revealed, the price of Treace Medical’s stock fell nearly 63%, to close at $4.17 per share on May 8, 2024.

What Now: You may be eligible to participate in the class action against Treace Medical Concepts, Inc. Shareholders who want to serve as lead plaintiff for the class must file their papers with the court by June 10, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.  

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Treace Medical Concepts, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a856d076-20b2-480b-84ce-d3e6ee3a1e79

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Alicia Basir’s April Love Ritual Reconnects Sweethearts for 2026 Wedding

Vapofil Claims Evaluated: 2026 Report on Vapofil Ingredients, Pricing, and What Consumers Should Verify Before Purchasing

HDFC ERGO Shares Tips on Keeping Your No-Claim Bonus Growing for Bigger Long-Term Savings

Free Spins No Deposit Casino Bonus 2026 | Online Casino Real Money No Deposit By My Bookie

Taurox (TAUX) Announced Phase 3 of The Presale Closure After The Last Development Update

Ledruval Unveiled: Is Ledruval Trading Platform Legit? Official Insights, Features & User Feedback

Taurox (TAUX) Announced a Huge Milestone Little After Launch, Receiving Massive Support From Investors

TitanPlay Explores the Role of Friction in Supporting Responsible Gambling Behavior in Ontario

Wall Street’s Worst Quarter Since 2022 Puts Bitcoin Everlight’s Fee-Based Model in Focus

Editors Picks

Vapofil Claims Evaluated: 2026 Report on Vapofil Ingredients, Pricing, and What Consumers Should Verify Before Purchasing

April 4, 2026

CFIA continues recall for Tim Hortons heat-activated mugs after reports of burn risk

April 4, 2026

HDFC ERGO Shares Tips on Keeping Your No-Claim Bonus Growing for Bigger Long-Term Savings

April 4, 2026

Free Spins No Deposit Casino Bonus 2026 | Online Casino Real Money No Deposit By My Bookie

April 4, 2026

Latest News

Taurox (TAUX) Announced Phase 3 of The Presale Closure After The Last Development Update

April 4, 2026

Ledruval Unveiled: Is Ledruval Trading Platform Legit? Official Insights, Features & User Feedback

April 4, 2026

2 dead in overnight Brampton shooting after altercation: police

April 4, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version